You are here

LUCERNA INC

Company Information
Address
760 PARKSIDE AVE STE 327C
BROOKLYN, NY 11226-1787
United States


http://www.lucernatechnologies.com

Information

UEI: J3MWGA6WFCG3

# of Employees: 7


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Fluorescent reporters for real time single cell Pol III transcription measurement

    Amount: $176,165.00

    SUMMARY RNA polymerase III Pol III is increasingly recognized as an important drug target and a rapidly developing area of academic research Pol III is responsible for generating RNAs that are crit ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  2. Splice sensors for cancer drug discovery

    Amount: $224,251.00

    SUMMARY Targeting pyruvate kinase remains a challenge in cancer drug discovery Despite compelling evidence highlighting the importance of the pyruvate kinase isoform M PKM in cancer cell growth ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  3. Fluorescent RNA foci assay for FXTAS drug discovery

    Amount: $207,922.00

    PROJECT SUMMARY Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurodegenerative disorder that that predominately affects adults over the age of 50. Individuals afflicted with ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  4. New toolkit to visualize RNAs in living cells

    Amount: $1,248,733.00

    DESCRIPTION provided by applicant Over the past years it has become increasingly apparent that there is exceptional complexity in the RNA population in cells This diverse RNA pool includes micr ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  5. Live-Cell Assays of ER and Golgi Enzyme Activities

    Amount: $298,937.00

    DESCRIPTION: Sirtuins and ADP ribosyltransferases (ARDTs) are two families of related enzymes that have important medically relevant functions. For example, SIRT3, a mitochondrial sirtuin, controls m ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  6. SBIR Phase I: Live-cell metabolite sensors for improving biofuel production

    Amount: $149,733.00

    This Small Business Innovation Research (SBIR) Phase I project involves the development of fluorescent metabolite sensors that enable high-throughput screening of genetically improved biofuel-producin ...

    SBIRPhase I2013National Science Foundation
  7. Methyltransferease sensors for homogenous HTS assays

    Amount: $216,247.00

    DESCRIPTION (provided by applicant): Methyltransferases (MTs) are a diverse class of enzymes that catalyze the transfer of a methyl group from S-adenosylmethionine (SAM) to a substrate molecule. MTs c ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  8. New toolkit to visualize RNAs in living cells

    Amount: $315,412.00

    DESCRIPTION (provided by applicant): Over the past 10 years it has become increasingly apparent that there is exceptional complexity in the RNA population in cells, including microRNAs, Piwi-interacti ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  9. Clozapine Sensors for Improving Therapeutic Treatments of Schizophrenia

    Amount: $328,597.00

    DESCRIPTION (provided by applicant): Schizophrenia is a chronic and debilitating brain disorder that affects about 1.1 percent of the US population age 18 and older in a given year and account for 5% ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government